KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Teva Pharmaceutical Industries (TEVA) Finished Goods (2016 - 2018)

Teva Pharmaceutical Industries filings provide 9 years of Finished Goods readings, the most recent being $2.7 billion for Q4 2018.

  • On a quarterly basis, Finished Goods fell 0.89% to $2.7 billion in Q4 2018 year-over-year; TTM through Dec 2018 was $2.7 billion, a 0.89% decrease, with the full-year FY2018 number at $2.7 billion, down 0.89% from a year prior.
  • Finished Goods hit $2.7 billion in Q4 2018 for Teva Pharmaceutical Industries, down from $2.7 billion in the prior quarter.
  • In the past five years, Finished Goods ranged from a high of $2.8 billion in Q4 2016 to a low of $2.1 billion in Q4 2015.
  • Median Finished Goods over the past 5 years was $2.7 billion (2017), compared with a mean of $2.6 billion.
  • Biggest five-year swings in Finished Goods: fell 11.65% in 2014 and later skyrocketed 38.15% in 2016.
  • Teva Pharmaceutical Industries' Finished Goods stood at $2.3 billion in 2014, then fell by 9.61% to $2.1 billion in 2015, then surged by 38.15% to $2.8 billion in 2016, then decreased by 5.05% to $2.7 billion in 2017, then fell by 0.89% to $2.7 billion in 2018.
  • The last three reported values for Finished Goods were $2.7 billion (Q4 2018), $2.7 billion (Q3 2018), and $2.7 billion (Q2 2018) per Business Quant data.